medigraphic.com

2014, Number 2

Next >>

Rev Cuba Endoc 2014; 25 (2)

Clinical, ultrasonographic and anatomopathological characteristics of patients operated on for suspected thyroid malignancy

Infante AA, Rodríguez OZ, Ramos DR

Language: Spanish
References: 24
Page: 35-45
PDF size: 110.21 Kb.


ABSTRACT

Introduction: thyroid carcinoma is characterized by slow progression and high recovery percentage.
Objective: to describe the clinical, ultrasonographic and anatomopathological characteristics of patients operated on for thyroid malignancy.
Methods: retrospective and descriptive study for which the primary data were collected from the medical histories of patients who met the inclusion criteria. These criteria comprised surgery for suspected thyroid malignancy, age over 18 years, and complete demographic, clinical, ultrasonographic and anatomopathological data and registration at the hospital. Frequency distribution tables were drawn up. The ratio comparison test was applied to describe the statistical significance of the studied variables with respect to the thyroid malignancy.
Results: in the group of patients with thyroid malignancy, 81.8 % were females, 39.4 % aged 41 to 50 years. The ultrasonographic test showed that 75.8 % of them had a thyroid nodule area greater than 10 mm, 53.3 % presented solitary nodule morphology whereas the result of the fine needle aspiration cytology was thyroid carcinoma. The histological classification yielded papillary carcinoma in 91 % of patients.
Conclusions: the papillary carcinoma was the most common, particularly in females aged 41 to 50 years who had over 1 cm nodules.


REFERENCES

  1. Brennan M, French J. Thyroid lumps and bumps. Aus Fam Phys. 2007;36(7):531-6.

  2. Kunz MW, Mizmar A, Wille G, Ahmad R, Miccoli P. Manejo actualizado del nódulo tiroideo. Ann Med (Mex). 2010;55(4):195-206.

  3. Frates MC, Benson CB, Doubilet PM, Kunreuther E, Contreras M, Cibas ES, et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab. 2006;91:3411-7.

  4. Secretaría de Salud de México. Guía de práctica clínica, diagnóstico y tratamiento del tumor maligno de tiroides [homepage en Internet]. Secretaría de Salud; 2009 México DF [citado 10 de agosto de 2013]. Disponible en: http://www.cvsp.cucs.udg.mx/guias/...TIROIDEO/IMSS_354_09_EyR.pdf%E2% 80%8E

  5. Haselkorn T, Bernstein L, Preston-Martin S, Cozen W, Mack WJ. Descriptive epidemiology of thyroid cancer in Los Angeles Country 1972-1995. Cancer Causes Control. 2007;11(2):163-70.

  6. Gritzmann N, Koischwitz D, Rettenbacher T. Sonography of the thyroid and parathyroid glands. Radiol Clin North Am. 2004;38:1131-45.

  7. Haber RS. Role of ultrasonography in the diagnosis and management of thyroid cancer. Endocr Pract. 2006;6:396-400.

  8. Stara DD, Clark OH, Gooding GA, Moss AA. High-resolution ultrasonographic and computed tomography of thyroid lesions in patients with hyperparathyroidism. Surgery. 2004;94:863-8.

  9. Duff BJ, Fitzgerald PJ. Cancer of the thyroid in children: report of 28 cases. J Clin Endocrinol Metab. 2006;10:1296-308.

  10. Rossing MA, Cushing KL, Voigt LF, Wicklund KG, Daling JR. Risk of papillary thyroid cancer in women in relation to smoking and alcohol consumption. Epidemiol. 2000;11(1):49-54.

  11. Uchino S, Noguchi S, Kawamoto H, Yamashita H, Watanabe S, Yamashita H, et al. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J Surg. 2002;26:897-902.

  12. Raush P, Nowels K, Jeffrey RB. Ultrasonographically guided thyroid biopsy: a review with emphasis on technique. J Ultrasound Med. 2001;20:79-85.

  13. Valenciaga JL, Galán Y, Turcios SE, Piña Y, Navarro D, Barroso O. Cáncer de tiroides en Cuba: estudio de 14 años. Rev Cubana Endocrinol [serie en Internet]. 2005 [citado 20 de febrero de 2014];16(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561- 29532005000300002&lng=es&nrm=iso&tlng=es

  14. Solt I, Gaititni D, Pery M, Hochberg Z, Stein M, Aarhus MW. Comparing thyroid ultrasonography to thyroid function in long-term survivors of childhood lymphoma. Med Pediatr Oncol. 2006;25:35-40.

  15. Vargas H. Enfoque del paciente con nódulo tiroideo. Med UIS. 2008;21(2):76-85.

  16. The American Thyroid Association Guidelines Taskforce. Management guidelines for patients with Thyroid nodules and Differentiated thyroid cancer. Thyroid. 2006;16(2):1-34.

  17. Cossu A, Budroni M, Paliogiannis P, Palmieri G, Scognamillo F, Cesaraccio R, et al. Epidemiology of Thyroid Cancer in an Area of Epidemic Thyroid Goiter. J Cancer Epidemiol. 2013;13:584-8.

  18. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors. J Cancer Epidemiol. 2013;2013:965-72.

  19. Dal Maso L, Lise M, Zambon P. Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects. Ann Oncol. 2011;22(4):957-63.

  20. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2009;19(11):1-48.

  21. Kamran SC. Thyroid nodule size predictive of risk for follicular carcinoma. J Clin Endocrinol Metab. 2013;10:2012-29.

  22. Scopa C. Histopathology of Thyroid Tumors. An Overview. Hormones. 2004;3(2):100-10.

  23. Kilfoy A, Kaplan BL, Chiu BC, Angelos P, Grogan R. The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States. Ann Surg Oncol. 2013;13:1068-92.

  24. Kilfoy A, Ward M, Sabra M, Devesa S. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid. 2011;21(2):125-34.




2020     |     www.medigraphic.com